RecruitingNCT07151339

Pilot Project Renal and Cardiovascular Tertiary Prevention in Preeclampsia

Pilotprojekt Renale Und kardiovaskuläre Tertiärprävention Nach Präeklampsie


Sponsor

University Hospital Schleswig-Holstein

Enrollment

100 participants

Start Date

Nov 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Tertiary prevention program for women with preeclampsia, HELLP syndrome, kidney disease and pregnancy or associated conditions, including founding of a biobank. (Observational study since no interference with regular path of treatment suggested in national and international guidelines)


Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria2

  • older than 18 yrs
  • diagnosed preeclampsia, HELLP syndrome or kidney disease durig pregnancy

Exclusion Criteria1

  • unable for informed consent

Locations(1)

University Hospital Schleswig- Holstein

Kiel, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07151339


Related Trials